Industry-wide Acceptance of Defendant’s Practice Undermines Allegation of Knowing Fraud on FDA; United States Court of Appeals for the Fourth Circuit No. 19-2042, U.S. ex rel. Liubov Skibo and Edward Patt v. Greer Laboratories Inc.
The Fourth Circuit affirmed a district court’s grant of summary judgment in favor of the defendants in a qui tam case alleging fraud on the Food and Drug Administration and unlawful employment retaliation under the FCA.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
$750/year